Data Shows Pomelo's Virtual Care Model Reduces Total Cost of Maternal Care in Medicaid Population, Lowers NICU and ER Utilization for...
Mana's lung-targeting AI model initially yielded a highly-specific, lung-tropic LNPIterative in-silico / in-vitro cycles improved in-vivo potency by ~100X in 3-months Data...
Strategic Partnerships Increase Reach to 11 Locations Across 5 States ANNAPOLIS, Md., Dec. 11, 2024 /PRNewswire/ -- Altruix, a leading...
BASEL, Switzerland and BOSTON, Dec. 11, 2024 /PRNewswire/ -- Lyfegen, a global leader in drug rebate management technology, today announced...
WASHINGTON, Dec. 11, 2024 /PRNewswire/ -- Paragon Health Institute, a leader in healthcare research and market-based policy proposals, has released...
The 2025 Black Book of Global Healthcare IT user polls reveal a critical need to modernize NHS EHR systems to...
Dry Powder Epinephrine Product Demonstrates Reliable and Consistent Delivery in Real-World Dosing Situations with a Heat-Stable Formulation RALEIGH, NC /...
Inretio presents initial clinical trial results at prestigious BRAIN Conference 2024 in London.Toronto, Ontario--(Newsfile Corp. - December 11, 2024) -...
Clearstep's Smart Access solution will serve as a cornerstone of the Digital Front Door program, intended to modernize military healthcare...
The overview presentation will review some of the Company’s recent achievements as well as the outlook for upcoming data milestonesJERUSALEM,...
TOKYO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (the “Company” or “MEDIROM”) announces that two...
JEDDAH, Saudi Arabia, Dec. 11, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) in Jeddah successfully...
The Company will review on Thursday, December 12th, at 12:00 p.m. EST. GARDEN CITY, NY, Dec. 11, 2024 (GLOBE NEWSWIRE)...
The ongoing obesity Phase 2 trial is a randomized, double-blind, placebo-controlled, dose finding, clinical trial to evaluate the safety and...
Median overall survival (OS) among patients with HR+, HER2- advanced breast cancer who were treatment-naïve in the advanced setting was...
Positive topline data for CAN-2409 viral immunotherapy achieved primary endpoint by demonstrating statistically significant and clinically meaningful benefit when combined...
US$452 million transaction at deemed price of US$3.20 per NewGen share Increased market capitalization and visibility will support NewGen’s continued...
ESO-T01 is the first in vivo BCMA CAR-T candidate to reach the clinical stage Early clinical data are expected in...
Grant for "Personalized Medicine Enabled by Intelligent Sensing Systems” ProjectMUNICH, Dec. 11, 2024 (GLOBE NEWSWIRE) -- HMNC Brain Health, a...
Burlington, Ontario--(Newsfile Corp. - December 11, 2024) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the...